Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287753 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2023. Verfasst von Marília Cristina Santos de Medeiros und 4 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil. Hauptthemen laut MEDLINE: Overweight, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Background
Systemic lupus erythematosus (SLE) is an autoimmune and inflammatory disease that requires treatment with hydroxychloroquine and glucocorticoids. Glucocorticoids are responsible for adverse effects such as increased weight, which can modify the severity and chronicity of autoimmune pathologies.
Aim
To summarize scientific evidence regarding the impact of overweight and obesity on disease activity and remission in SLE.
Methods
The protocol was developed according to the Preferred Reporting Items for Systematic Review and Meta-analysis Protocol (PRISMA-P) and published in the International Prospective Register of Systematic Reviews database (PROSPERO—CRD42021268217). PubMed, Scopus, Embase, and Google Scholar will be searched for observational studies including adult patients with SLE who were overweight and obese or not, that included disease activity or remission as outcomes. The search is planned for May 2023. Three independent authors will select the eligible articles and extract their data. Subsequently, three authors will independently extract data from each included study using an extraction form created by the researchers. Methodological quality analyses will be performed using the modified Newcastle-Ottawa scale. The results will be presented as a narrative synthesis according to the synthesis without a meta-analysis reporting guideline (SWiM). Meta-analysis will be conducted where appropriate using random-effects models. Expected results This review will identify the impact of overweight and obesity on the clinical features of SLE, helping clinicians manage disease activity and remission, both important to optimize disease outcomes and patient quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
- Department of Clinical and Toxicological Analyses, Federal University of Rio Grande Do Norte, Natal, Brazil.
- Graduate Program of Biotechnology, Universidade Potiguar (UnP), Natal, RN, Brazil.
- Graduate Program in Sciences Applied to Women's Health, Maternidade Escola Januário Cicco (MECJ/ EBSERH), Federal University of Rio Grande do Norte, Natal, Brazil.
ORCID-Profile: Ony Araújo Galdino, Ricardo Ney Cobucci, Adriana Augusto de Rezende
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Medeiros, M. C. S., Souza, K. S. C., Galdino, O. A., Cobucci, R. N., & de Rezende, A. A. (2023). Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0287753
Vancouver
Medeiros MCS, Souza KSC, Galdino OA, Cobucci RN, de Rezende AA. Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol. PLOS ONE. 2023. doi:10.1371/journal.pone.0287753
BibTeX
@article{Medeiros2023,
author = {Medeiros, Marília Cristina Santos de and Souza, Karla Simone Costa de and Galdino, Ony Araújo and Cobucci, Ricardo Ney and de Rezende, Adriana Augusto},
title = {Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287753}
}
EUVIMED